berbamine has been researched along with Chronic Hepatitis C in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cloherty, APM; Ennis, S; Jean, F; Muncan, V; Niikura, M; Patel, KS; Pérez-Vargas, J; Rader, AG; Ribeiro, CMS; Schreurs, RRCE; Thompson, CAH; Wildenberg, ME | 1 |
1 other study(ies) available for berbamine and Chronic Hepatitis C
| Article | Year |
|---|---|
Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade.
Topics: Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; Autophagy; COVID-19; Hepatitis C, Chronic; Humans; Membrane Proteins; Post-Acute COVID-19 Syndrome; RNA, Viral; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2023 |